Cargando…
Activated Protein C (APC) and 3K3A-APC-Induced Regression of Choroidal Neovascularization (CNV) Is Accompanied by Vascular Endothelial Growth Factor (VEGF) Reduction
The activated protein C (APC) ability to inhibit choroidal neovascularization (CNV) growth and leakage was recently shown in a murine model. A modified APC, 3K3A-APC, was designed to reduce anticoagulant activity while maintaining full cytoprotective properties, thus diminishing bleeding risk. We ai...
Autores principales: | Livnat, Tami, Weinberger, Yehonatan, Fernández, José A., Bashir, Alaa, Ben-David, Gil, Palevski, Dahlia, Levy-Mendelovich, Sarina, Kenet, Gili, Budnik, Ivan, Nisgav, Yael, Griffin, John H., Weinberger, Dov |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996919/ https://www.ncbi.nlm.nih.gov/pubmed/33652861 http://dx.doi.org/10.3390/biom11030358 |
Ejemplares similares
-
3K3A-Activated Protein C Inhibits Choroidal Neovascularization Growth and Leakage and Reduces NLRP3 Inflammasome, IL-1β, and Inflammatory Cell Accumulation in the Retina
por: Weinberger, Yehonatan, et al.
Publicado: (2023) -
3K3A-Activated Protein C Prevents Microglia Activation, Inhibits NLRP3 Inflammasome and Limits Ocular Inflammation
por: Palevski, Dahlia, et al.
Publicado: (2022) -
Possible involvement of NETosis in inflammatory processes in the eye: Evidence from a small cohort of patients
por: Barliya, Tilda, et al.
Publicado: (2017) -
The Histone Deacetylase Inhibitor AN7, Attenuates Choroidal Neovascularization in a Mouse Model
por: Dahbash, Mor, et al.
Publicado: (2019) -
Real-World Data on Bleeding Patterns of Hemophilia A Patients Treated with Emicizumab
por: Levy-Mendelovich, Sarina, et al.
Publicado: (2021)